IMPLANT SITE SWELLING

This adverse event was reported 1019 times

These drugs are most commonly taken by patients reporting IMPLANT SITE SWELLING:

# Drug Count
0 ETONOGESTREL 581
1 BACLOFEN 90
2 BACLOFEN INJECTION 58
3 HYDROMORPHONE HYDROCHLORIDE 22
4 TESTOSTERONE 19
5 DIAZEPAM 16
6 BUPIVACAINE 14
7 BUPIVACAINE HYDROCHLORIDE IN DEXTROSE 14
8 LIDOCAINE HYDROCHLORIDE 14
9 LIDOCAINE 13
See all common drugs associated with IMPLANT SITE SWELLING

IMPLANT SITE SWELLING is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AFAMELANOTIDE 1 0.0476
1 BACLOFEN INJECTION 58 0.0186
2 HISTRELIN ACETATE 10 0.0114
3 ETONOGESTREL 581 0.0101
4 FLOXURIDINE 1 0.0058
5 BORON 1 0.0033
6 ZICONOTIDE ACETATE 8 0.0033
7 BUPIVACAINE HYDROCHLORIDE IN DEXTROSE 14 0.0018
8 TAZAROTENE 2 0.0017
9 FERROUS ASPARTO GLYCINATE, IRON, ASCORBIC ACID, FOLIC ACID, CYANOCOBALAMIN, ZINC, AND SUCCINIC ACID 1 0.0016
See all drugs enriched for association with IMPLANT SITE SWELLING

IMPLANT SITE SWELLING is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Progestin [EPC] 582 0.0020
1 gamma-Aminobutyric Acid-ergic Agonist [EPC] 143 0.0016
2 Nitrogen Binding Agent [EPC] 2 0.0008
3 Androgen [EPC] 19 0.0007
4 Amide Local Anesthetic [EPC] 29 0.0003
5 Calcitonin [EPC] 1 0.0003
6 Carnitine Analog [EPC] 1 0.0003
7 Provitamin D2 Compound [EPC] 8 0.0003
8 Ester Local Anesthetic [EPC] 12 0.0002
9 Antiseptic [EPC] 1 0.0002
See all drug classes enriched for association with IMPLANT SITE SWELLING